Primary Insomnia Clinical Trial
Official title:
The Effects of Mindfulness and RelaxationTraining for Insomnia (MRTI) on Postmenopausal Women: a Randomized Clinical Trial.
NCT number | NCT01593436 |
Other study ID # | 0708/11 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2011 |
Est. completion date | July 2015 |
Verified date | April 2018 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Summary
Introduction: Insomnia is a symptom of sleep disorders most prevalent. Primary insomnia, the
investigators analyzed, often related to stress states acquired, generalized anxiety and
stress, which are important factors that disrupt normal sleep. The investigators point out a
fact that still intrigue the students of medicine and sleep that is distorted perception of
sleep by the sleepless nights, polysomnography shows greater effectiveness than that
perceived by them. On the other hand, there is evidence that mindfulness techniques may
reduce symptoms of stress and anxiety as well as improve the general attention, which may
contribute to a better perception of the effectiveness of sleep. In addition, there are
studies showing that meditation is associated with metabolic and neurophysiological
characteristics similar to normal sleep. Objectives: To compare sleepless menopausal women
trained for 8 weeks in the technique of mindfulness insomniac postmenopausal untrained and
also assess the quality of sleep experienced meditators menopausal comparing them to the
group of healthy postmenopausal women untrained in the art.
Status | Completed |
Enrollment | 54 |
Est. completion date | July 2015 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 50 Years to 66 Years |
Eligibility |
Inclusion Criteria:Inclusion criteria for postmenopausal women with insomnia: - be available to attend any training program of mindfulness (1 time per week for 8 weeks) and perform the suggested practices home. - be available to perform the tests at home polysomnography (overnight) and other tests. - Be available to perform the blood collection - meet the criteria established in accordance with DSM-IV-TR for insomnia - age 50 to 65 years. - Women in menopause: women presenting with absence of menstruation in the past year and either FSH greater than 30. - Have a BMI value lower than 30. - Not having undergone any previous treatment against insomnia. - Not having made use of hypnotics for at least 15 days. Inclusion criteria for women without menopausal insomnia - be available to perform the examinations polysomnographic (overnight) and other tests. - To meditators, having trained as a practice of mindfulness meditation for at least 3 years 3 times a week. - Age: 50 to 65 years - Being a woman and being in menopause: women presenting failures or lack of regular menstrual periods last year. Exclusion Criteria:Exclusion criteria for menopausal women with insomnia - being under drug treatment, subjects will not be accepted that use of benzodiazepines, antihistamines, hypnotics, herbal sleeping pills, sedatives, antidepressants, antipsychotics, stimulants (amphetamine, caffeine, modafinil), corticosteroids, bronchodilators and beta blockers. - being under psychological or psychiatric treatment. - present history of neurological or psychiatric diseases such as severe psychotic disorders. - having other sleep disorders like narcolepsy, sleep-disordered breathing, sleep apnea with an index greater than 15 / h, circadian rhythm disorder or parasomnias. - 4 years of schooling below complete primary school Exclusion criteria for menopausal women without complaints of insomnia: - being under drug treatment, subjects will not be accepted that use of benzodiazepines, antihistamines, hypnotics, herbal sleeping pills, sedatives, antidepressants, antipsychotics, stimulants (amphetamine, caffeine, modafinil), corticosteroids, bronchodilators and beta blockers. - being in psychological treatments. - having had contact with a meditation technique. - present history of neurological or psychiatric diseases such as severe psychotic disorders, as well as anxiety and depression. - women presenting failures or regular period last year. - 4 years of schooling below complete primary school - submit any sleep disorders |
Country | Name | City | State |
---|---|---|---|
Brazil | Associacao Fundo de Incentivo a Psicofarmacologia Sao Paulo, SP, Brazil | Sao Paulo | Sp |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo | Associação Fundo de Incentivo à Pesquisa |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The investigators intend to evaluate the effectiveness of mindfulness training in postmenopausal women with insomnia | The insomniacs were trained for 8 weeks in mindfullness,and they had a 30-minute meditation class once a week. They also received a meditation audio,to practice three times a day for 15 minutes in their homes.The control group was not infirm intervention. The meditation group showed relief of the symptoms of insomnia, indicated by Pittsburgh Insomnia Index, actigraphy and polysomnography, improving the overall quality of sleep and decreasing number of awakening.The control group remained with the same symptoms and complaints of insomnia. | two years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03461666 -
Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia
|
N/A | |
Recruiting |
NCT02243501 -
Better Nights, Better Days for Typically Developing Children
|
N/A | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
Completed |
NCT00770510 -
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
|
Phase 2/Phase 3 | |
Completed |
NCT00520832 -
A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
|
Phase 2 | |
Recruiting |
NCT00415714 -
Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
|
N/A | |
Terminated |
NCT00420810 -
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
|
Phase 3 | |
Completed |
NCT00178048 -
Paroxetine in the Treatment of Chronic Primary Insomnia
|
Phase 4 | |
Completed |
NCT00816673 -
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
|
Phase 2 | |
Completed |
NCT01960452 -
A High Density EEG Comparison of Sleep Patterns in Insomnia
|
N/A | |
Completed |
NCT01957111 -
Metabolomics of Insomnia-Related Hyperarousal
|
N/A | |
Completed |
NCT01181232 -
A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients
|
Phase 4 | |
Completed |
NCT00784875 -
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
|
Phase 2 | |
Completed |
NCT00551148 -
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
|
Phase 2 | |
Completed |
NCT00397189 -
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
|
Phase 3 | |
Completed |
NCT00352144 -
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
|
Phase 3 | |
Completed |
NCT02290405 -
Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
|
||
Completed |
NCT03314441 -
Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia
|
N/A | |
Completed |
NCT00792298 -
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
|
Phase 2 | |
Completed |
NCT01021852 -
Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
|
Phase 2 |